Stocks
Arcutis Biotherapeutics (ARQT) EV/EBITDA US GAAP (year values) |
||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | |||
| EV/EBITDA | ? | -3.47 | 0.70 | 0.29 | -14.3 | 1 403 | 222.1 | |
| Changes by years, y/y, % | -35% | -120% | -59% | -5 032% | -9 914% | |||
Arcutis Biotherapeutics. EV/EBITDA
Arcutis Biotherapeutics. EV/EBITDA, changes, %
Arcutis Biotherapeutics (ARQT) EV/EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | FY2026Q2 | LTM ? | |||
| EV/EBITDA | ? | -24.8 | -97.2 | 1 333 | 195.5 | 74.7 | 222.1 | |
| Changes by years, y/y, % | -2 710% | +1 436% | -9 422% | -1 149% | -401% | |||
| Changes by quarters, q/q, % | +33% | +292% | -1 471% | -85% | -62% | |||
